{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:45:53Z","timestamp":1793310353896,"version":"4.5.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.581839","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:28:40Z","timestamp":1605659320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin"],"prefix":"10.3389","volume":"11","author":[{"given":"Jing","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Fombuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Routy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867326666190124121725","article-title":"Obesity Therapy: How and Why","volume":"27","author":"Paccosi","year":"2020","journal-title":"Curr Med Chem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"110103","DOI":"10.1016\/j.biopha.2020.110103","article-title":"Angiogenesis in obesity","volume":"126","author":"Nijhawans","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/cd18-0105","article-title":"Standards of Medical Care in Diabetes-2019 Abridged for Primary Care Providers","volume":"37","year":"2019","journal-title":"Clin Diabetes Publ Am Diabetes Assoc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.jcjd.2017.10.010","article-title":"Hypoglycemia","volume":"42","author":"Yale","year":"2018","journal-title":"Can J Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2013.01.021","article-title":"Pharmacologic management of type 2 diabetes","volume":"37","author":"Harper","year":"2013","journal-title":"Can J Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13578","article-title":"Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U\/mL in a patient-level pooled analysis of EDITION 1, 2 and 3","volume":"21","author":"Bonadonna","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4352-x","article-title":"The effects of metformin on gut microbiota and the immune system as research frontiers","volume":"60","author":"Pollak","year":"2017","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.07.165","article-title":"Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells","volume":"425","author":"Kim","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-008-1137-7","article-title":"Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits","volume":"24","author":"Li","year":"2009","journal-title":"Heart Vessels"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.07.017","article-title":"Metformin modulates human leukocyte\/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients","volume":"242","author":"Victor","year":"2015","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e192553","DOI":"10.1001\/jamaoncol.2019.2553","article-title":"Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial","author":"Arrieta","year":"2019","journal-title":"JAMA Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25958","article-title":"Metformin and COVID-19: A novel deal of an old drug","volume":"92","author":"El-Arabey","year":"2020","journal-title":"J Med Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e8758","DOI":"10.1371\/journal.pone.0008758","article-title":"Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1","volume":"5","author":"Onken","year":"2010","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2019.08.003","article-title":"Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy","volume":"178","author":"Pryor","year":"2019","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2650","article-title":"Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1299","article-title":"Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0826","article-title":"Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial","volume":"180","author":"Ejtahed","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13543784.2020.1705277","article-title":"Obesity medications in development","volume":"29","author":"Rebello","year":"2020","journal-title":"Expert Opin Invest Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EJE-18-0847","article-title":"GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans","volume":"180","author":"Papathanasiou","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0146-4","article-title":"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss","volume":"1","author":"Day","year":"2019","journal-title":"Nat Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa338","article-title":"Repurposing metformin in non-diabetic people living with HIV: Influence on weight and gut microbiota","volume":"7","author":"Isnard","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2018.12.027","article-title":"The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease","volume":"35","author":"Benes","year":"2019","journal-title":"Can J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2019.1678565","article-title":"The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update","volume":"57","author":"Arkoumani","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-020-10041-3","article-title":"Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients","volume":"37","author":"Spanopoulou","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"eaan8732","DOI":"10.1126\/scitranslmed.aan8732","article-title":"Long-acting MIC-1\/GDF15 molecules to treat obesity: Evidence from mice to monkeys","volume":"9","author":"Xiong","year":"2017","journal-title":"Sci Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000455907","article-title":"Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort","volume":"7","author":"You","year":"2017","journal-title":"Cardiorenal Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1601298","DOI":"10.1183\/13993003.01298-2016","article-title":"Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD","volume":"49","author":"Huseb\u00f8","year":"2017","journal-title":"Eur Respir J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004572","article-title":"Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism","volume":"136","author":"Hansen","year":"2020","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions","volume":"318","author":"Schlittenhardt","year":"2004","journal-title":"Cell Tissue Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2354","article-title":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice","volume":"17","author":"Kempf","year":"2011","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2005.07.010","article-title":"Link between obesity and type 2 diabetes. Best practice & research","volume":"19","author":"Golay","year":"2005","journal-title":"Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.11.1619","article-title":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.2005.039032","article-title":"Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors","volume":"82","author":"Daousi","year":"2006","journal-title":"Postgraduate Med J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000676","article-title":"The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security","volume":"26","author":"Zumla","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.005","article-title":"Effect of thiazolidinediones on body weight in patients with diabetes mellitus","volume":"115","author":"Fonseca","year":"2003","journal-title":"Am J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"Cd002966","DOI":"10.1002\/14651858.CD002966.pub3","article-title":"Metformin monotherapy for type 2 diabetes mellitus","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315441","article-title":"Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles","volume":"41","author":"Hermann","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association Of Clinical Endocrinologists And American College Of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care Of Patients With Obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0032-1327734","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/0269881109353461","article-title":"Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis","volume":"25","author":"Bj\u00f6rkhem-Bergman","year":"2011","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B56","article-title":"Beneficial effects of sitagliptin and metformin in non-diabetic hypertensive and dyslipidemic patients","volume":"29","author":"Hussain","year":"2016","journal-title":"Pakistan J Pharm Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2004.08.004","article-title":"Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals","volume":"71","author":"Rodr\u00edguez","year":"2004","journal-title":"Prostagland Leukotrienes Essential Fatty Acids"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0241","article-title":"Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin","volume":"91","author":"Srinivasan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e20164285","DOI":"10.1542\/peds.2016-4285","article-title":"Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial","volume":"140","author":"Pastor-Villaescusa","year":"2017","journal-title":"Pediatrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12426","article-title":"Effects of metformin on energy intake and satiety in obese children","volume":"17","author":"Adeyemo","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1542\/peds.107.4.e55","article-title":"The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis","volume":"19","author":"Barton","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"B63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/0269881119885918","article-title":"Effects of long-term antipsychotics treatment on body weight: A population-based cohort study","volume":"34","author":"Bazo-Alvarez","year":"2020","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis","volume":"16","author":"de Silva","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e0156208","DOI":"10.1371\/journal.pone.0156208","article-title":"Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis","volume":"11","author":"Siskind","year":"2016","journal-title":"PloS One"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0571-z","article-title":"Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"32","author":"Ellul","year":"2018","journal-title":"CNS Drugs"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0173","article-title":"The effects of empagliflozin versus metformin on endothelial microparticles in overweight\/obese women with polycystic ovary syndrome","volume":"9","author":"Javed","year":"2020","journal-title":"Endocr Connect"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01825.x","article-title":"The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome","volume":"62","author":"Preiss","year":"2008","journal-title":"Int J Clin Pract"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3081","article-title":"Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study","volume":"11","author":"Jensterle","year":"2016","journal-title":"Exp Ther Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2013.03.002","article-title":"Body weight reduction and metformin: Roles in polycystic ovary syndrome","volume":"20","author":"Al-Nozha","year":"2013","journal-title":"Pathophysiology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1579-x","article-title":"Metformin 2,500\u00a0mg\/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile","volume":"282","author":"Aghahosseini","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1279597","article-title":"Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"33","author":"Patel","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9581","article-title":"The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: Mechanisms in Human Obesity and Weight Loss","volume":"8","author":"Yerevanian","year":"2019","journal-title":"Curr Obes Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1353\/hpu.2013.0044","article-title":"Metformin induces a senescence-associated gene signature in breast cancer cells","volume":"24","author":"Williams","year":"2013","journal-title":"J Health Care Poor Underserved"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3289","article-title":"Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition","volume":"35","author":"Zafarvahedian","year":"2017","journal-title":"Cell Biochem Funct"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1682","article-title":"Growth Differentiation Factor 15 as a Novel Biomarker for Metformin","volume":"40","author":"Gerstein","year":"2017","journal-title":"Diabetes Care"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13519","article-title":"Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study","volume":"21","author":"Natali","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.05.009","article-title":"High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K\/Akt\/eNOS pathway","volume":"18","author":"Ho","year":"2006","journal-title":"Cell Signal"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4161\/oxim.3.6.14415","article-title":"Signaling of reactive oxygen and nitrogen species in Diabetes mellitus","volume":"3","author":"Afanas\u2019ev","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e65549","DOI":"10.1371\/journal.pone.0065549","article-title":"Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2008.11.013","article-title":"p53 controls prostate-derived factor\/macrophage inhibitory cytokine\/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms","volume":"277","author":"Kelly","year":"2009","journal-title":"Cancer Lett"},{"key":"B88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00125-018-4751-7","article-title":"Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort","volume":"62","author":"Bao","year":"2019","journal-title":"Diabetologia"},{"key":"B89","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-020-01020-9","article-title":"The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes","volume":"19","author":"He","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"key":"B91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12981-020-00267-2","article-title":"Metformin effect on gut microbiota: insights for HIV-related inflammation","volume":"17","author":"Ouyang","year":"2020","journal-title":"AIDS Res Ther"},{"key":"B93","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of Metformin in Attenuating the Hallmarks of Aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4337-9","article-title":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes","volume":"60","author":"Griffin","year":"2017","journal-title":"Diabetologia"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2018.05.002","article-title":"Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond","volume":"29","author":"Mullican","year":"2018","journal-title":"Trends Endocrinol Metab: TEM"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101814200","article-title":"Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3","volume":"276","author":"Baek","year":"2001","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.01.089","article-title":"A p53-type response element in the GDF15 promoter confers high specificity for p53 activation","volume":"354","author":"Osada","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-0576-9","article-title":"NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells","volume":"12","author":"Lim","year":"2007","journal-title":"Apoptosis an Int J Programmed Cell Death"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201607110","article-title":"Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis","volume":"216","author":"Chung","year":"2017","journal-title":"J Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.044","article-title":"Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15","volume":"22","author":"Jones","year":"2018","journal-title":"Cell Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210658","article-title":"TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation","volume":"27","author":"Ichikawa","year":"2008","journal-title":"Oncogene"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.01.076","article-title":"Mediates Insulin Resistance by Modulating Adipose Tissue Macrophage Polarity","volume":"18","author":"Suzuki","year":"2017","journal-title":"Cell Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0466","article-title":"Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial","volume":"167","author":"Kempf","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz071","article-title":"Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults","volume":"75","author":"Semba","year":"2020","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","article-title":"TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator","volume":"8","author":"Tsai","year":"2013","journal-title":"PloS One"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.015","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia","volume":"131","author":"Baek","year":"2006","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e34868","DOI":"10.1371\/journal.pone.0034868","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets","volume":"7","author":"Macia","year":"2012","journal-title":"PloS One"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2006.10.009","article-title":"Loss of neurturin in frog\u2013comparative genomics study of GDNF family ligand-receptor pairs","volume":"34","author":"H\u00e4tinen","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1159\/000094087","article-title":"Evolution of the GDNF family ligands and receptors","volume":"68","author":"Airaksinen","year":"2006","journal-title":"Brain Behav Evol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.30.17644","article-title":"A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins","volume":"271","author":"Asai","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.581839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:28:42Z","timestamp":1605659322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.581839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":113,"alternative-id":["10.3389\/fendo.2020.581839"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.581839","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"article-number":"581839"}}